ExLibris header image
SFX Logo
Title: CD4 and Viral Load Dynamics in Antiretroviral-Naïve HIV-Infected Adults from Soweto, South Africa: A Prospective Cohort
Source:

Plos One [1932-6203] Martinson, Neil yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Andrade, A. "Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248." The Journal of infectious diseases 208.6 (2013): 884-891. Link to Full Text for this item Link to SFX for this item
2. Orman, Jennifer S S. "Tipranavir: a review of its use in the management of HIV infection." Drugs 68.10 (2008): 1435-63. Link to SFX for this item
3. Deleplancque, F. "Usefulness of a Fourth Generation ELISA Assay for the Reliable Identification of HCV Infection in HIV-Positive Adults from Gabon (Central Africa)." PLoS One 10.1 (2015). Link to Full Text for this item Link to SFX for this item
4. Lokody, I. "Pathogen genetics: Cutting out HIV." Nature reviews. Genetics (2014): 575-575. Link to SFX for this item
5. Haubrich, Richard H. "Initial Viral Decay to Assess the Relative Antiretroviral Potency of PI-, NNRTI- and NRTI-Sparing Regimens for First Line Therapy of HIV Infection." AIDS 25.18 (2011): 2269-2278. Link to SFX for this item
6. Hazra, R. "The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents." Journal of the International AIDS Society 16.1 (2013): 18555-8. Link to Full Text for this item Link to SFX for this item
7. Townsend, Mary U U. "Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance." Clinical therapeutics 29.11 (2007): 2309-18. Link to SFX for this item
8. Pancino, G. "Natural resistance to HIV infection: lessons learned from HIV-exposed uninfected individuals.(Natural Immunity to HIV Infection)(Report)." The Journal of infectious diseases 202.9 (2010). Link to Full Text for this item Link to SFX for this item
9. "KASL clinical practice guidelines: Management of Hepatitis C." Clinical and molecular hepatology 20.2 (2014): 89-139. Link to Full Text for this item Link to SFX for this item
10. Abdel-Hameed, Enass A. "Epigenetic modification of FOXP3 in patients with chronic HIV infection." Journal of acquired immune deficiency syndromes Publish Ahead of Print (2013): 1-26. Link to SFX for this item
11. Lu, H. "Site-Specific Antibody-Polymer Conjugates for siRNA Delivery." Journal of the American Chemical Society 135.37 (2013): 13885-13891. Link to Full Text for this item Link to SFX for this item
12. Stoove, M. "An urgent need to scale-up injecting drug harm reduction services in Tanzania: Prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011." International Journal of Drug Policy 24.1 (2012): 78-81. Link to SFX for this item
13. Lederman, M. "Viral dynamics and their relations to baseline factors and longer term virologic responses in treatment-naive HIV-1-infected patients receiving abacavir in combination with HIV-1 protease inhibitors." Journal of acquired immune deficiency syndromes 33.5 (2003): 557-563. Link to SFX for this item
14. Pantaleo, G. "New concepts in the immunopathogenesis of human immunodeficiency virus infection." The New England journal of medicine 328.5 (1993): 327-35. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.